Among the multiple cellular cascades that are activated by BCR-ABL, the PI3'K/AKT/mTOR pathway [5, 28-30] is of particular interest and has been the subject of extensive efforts by many groups in the CML and Ph+ ALL research fields. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.